Some thirty years ago, work on mammalian tissues suggested the presence of two cytosolic hexosaminidases in mammalian cells; one of these has been more recently characterized in a recombinant form and has an important role in cellular function due to its ability to cleave β-N-acetylglucosamine residues from a variety of nuclear and cytoplasmic proteins. However, the molecular nature of the second cytosolic hexosaminidase, named hexosaminidase D, has remained obscure. In the present study, we molecularly characterize for the first time the human and murine recombinant forms of enzymes, encoded by HEXDC genes, which appear to correspond to hexosaminidase D in terms of substrate specificity, pH dependency and temperature stability. Furthermore, a Myc-tagged form of this novel hexosaminidase displays a nucleocytoplasmic localization. Transcripts of the corresponding gene are expressed in a number of murine tissues. On the basis of its sequence, this enzyme represents, along with the lysosomal hexosaminidase subunits encoded by the HEXA and HEXB genes, the third class 20 glycosidase to be identified from mammalian sources.
- glycosidic hydrolase
β-Hexosaminidases (EC 184.108.40.206) are a class of glycoside hydrolases, widespread in nature and present in species from bacteria to man, which remove terminal GalNAc (N-acetylgalactosamine) or GlcNAc (N-acetylglucosamine) residues from a range of glycoconjugates, such as glycoproteins and glycolipids. It is especially the relationship of human hexosaminidases to lysosomal storage diseases, particularly Tay–Sachs and Sandhoff syndromes , which has ensured that this class of enzyme is relatively well-studied. In mammals, ‘acidic’ lysosomal β-hexosaminidases are homo- or hetero-dimeric enzymes consisting of different combinations of α and β subunits (Hex A, αβ; Hex B, ββ; Hex S, αα); these subunits are encoded by the HEXA and HEXB genes  and are classified by sequence homology as being members of retaining glycoside hydrolase family 20, as defined by the CAZy database . Other eukaryotic family 20 enzymes also include plant vacuole hexosaminidases as well as the insect FDL (fused lobes) proteins involved in N-glycan processing [4–6]; this family of enzymes adopts substrate-assisted catalysis with a transition state involving an oxazolinium ion . On the other hand, some β-hexosaminidases follow a different type of catalytic mechanism featuring a covalently linked glycosyl–enzyme intermediate ; these are members of glycoside hydrolase family 3 and are only found in bacteria.
Some years ago, a further β-hexosaminidase gene was molecularly identified from mammalian sources; this enzyme, OGA (O-GlcNAcase) [also know as NCOAT (nuclear cytoplasmic O-GlcNAcase and acetyltransferase) and encoded by the MGEA5 gene], is defined as a member of glycoside hydrolase family 84 and is predicted to display similarities to family 20 enzymes in terms of its mechanism and its overall protein fold [9,10]. The biological role of OGA is to reverse the action of the peptide N-acetylglucosaminyltransferase OGT (O-GlcNAc transferase). Both of these enzymes are important in intracellular signalling due to their effect on the intracellular balance of GlcNAc and phosphate modifications of nucleocytoplasmic proteins [11,12] and they may indeed associate with each other in vivo . Interestingly, however, 90% of the endogenous enzyme is cytoplasmic ; in the case of recombinant forms of OGA, the 130 kDa form is cytoplasmic  and the 75 kDa form is apparently nuclear . However, there still remains the question as to whether OGA is the only hexosaminidase in the nucleus and cytoplasm.
Suggestive of yet another β-hexosaminidase gene in mammals are some previous studies on soluble ‘neutral’ hexosaminidases from animal sources [17–21]; two types of non-lysosomal activity were found in bovine brain, with different substrate specificities and temperature stabilities, and were named hexosaminidases C and D. Whereas hexosaminidase C is probably identical to the aforementioned OGA [15,22], the origin of the hexosaminidase D activity has remained unknown; this latter enzyme has a bias towards N-acetylgalactosaminide substrates and has also been referred to as a neutral N-acetylgalactosaminidase . Recently, we have identified four β-hexosaminidases from Caenorhabditis elegans, which belong to a novel branch of the glycoside hydrolase family 20  and which also have a preference for aryl N-acetylgalactosaminides. Database searching indicated that their closest mammalian relatives are not the lysosomal hexosaminidases, but putatively soluble uncharacterized proteins; thus our question was whether these novel mammalian genes encoded enzymes with characteristics similar to those of the neutral N-acetylgalactosaminidase. We have, therefore, cloned the relevant human and murine cDNAs and expressed the encoded proteins in Escherichia coli. Indeed, both these proteins are now shown to be enzymatically active hexosaminidases with properties akin to those of the ‘historical’ hexosaminidase D activities.
MATERIALS AND METHODS
Cloning, expression and purification of hexosaminidase homologues
Mouse liver cells and HEK-293 cells (human embryonic kidney cells) were homogenized in TRIzol® reagent (Invitrogen) in order to isolate RNA, which was subsequently subjected to reverse transcription using Superscript III (Invitrogen). In order to clone the full predicted open reading frames, the primer pairs MouseHex/1/EcoRI (5′-CCGAATTCATGTCATCACCCACGCC-3′) and MouseHex/2/XhoI (5′-CCGCTCGAGTCAGGGGTTCTGCCCTG-3′) or HumanHex/1/EcoRI (5′-CGGAATTCATGTCAGGTTCCACTCCATTTC-3′) and HumanHex/2/XhoI (5′-CCGCTCGAGGCATGAGCTCTCCCCTCA-3′) were used together with Expand polymerase mix (Roche) at an annealing temperature of 58 °C in the presence of the GC-rich PCR additive (Roche). After digestion with the relevant enzymes, the fragments were ligated into the pET30a expression vector (Novagen), which encodes a His tag. Selected transformed E. coli TOP10F′ colonies were screened and the purified plasmids were subjected to DNA sequencing using the BigDye kit (Applera). Subsequently, sequence-verified plasmid DNA was used to transform E. coli BL21(DE3)pLysS cells and, after overnight cultivation at 37 °C in LB (Luria–Bertani) medium containing kanamycin and chloramphenicol, expression was induced in cultures with an attenduance (D) at 600 nm of ∼0.6 at room temperature (23 °C) in the presence of 1 mM IPTG (isopropyl β-D- thiogalactoside). In the case of trial expression, aliquots were removed at various time points prior to lysis, enzymatic assay and Western blotting with a 1:10000 dilution of a mouse anti-His antibody (HIS-1; Sigma). For larger-scale cultures, lysis and His-tag purification were performed as previously described for GDP-fucose biosynthesizing enzymes . Peptide mass fingerprinting by MALDI-TOF MS (matrix-assisted laser-desorption ionization–time-of-flight MS) was performed after tryptic digestion of SDS/PAGE separated proteins. Gel-filtration analysis of the His-tag purified murine hexosaminidase was performed on a Sephacryl S200 Superfine column equilibrated with 40 mM Tris/HCl (pH 7.8), 400 mM NaCl, 100 mM KCl, 250 mM imidazole, 10% (v/v) glycerol and 0.5% Triton X100. Approx. 0.75 mg of each of the standard proteins (human IgG, human apo-transferrin, chicken ovalbumin and bovine ribonuclease B) were used to calibrate the column. A modified Lowry protein determination kit (TP0300, Sigma) was used to analyse the fractions; aliquots (4 μl) of each fraction were then diluted with 44.75 μl of 0.4 M sodium citrate (pH 5.5) prior to assaying hexosaminidase activity for 1 h using p-nitrophenyl-β-GalNAc (see below).
Samples of crude E. coli lysates (5 μl) or of purified enzymes (0.25–0.5 μl) were assayed with p-nitrophenylglycosides; samples were incubated in microtitre wells with 25 μl of McIlvaine citrate-phosphate buffer (pH 3.5–8.0), 1.25 μl of 100 mM p-nitrophenylglycoside in DMSO [final concentrations of 2.5 mM glycoside and 2.5% (v/v) DMSO] and water (up to a final volume of 50 μl) for 1–2 h at 37 °C; in some cases, another assay duration, pH or temperature was employed. The reaction was stopped by addition of 250 μl of 0.4 M glycine/NaOH (pH 10.4), and the absorbance at 405 nm (A405) was read using a microtitre plate reader. The effect of typical hexosaminidase inhibitors were also tested in the present study: AdDNJ (2-acetamido-1,2-dideoxynojirimycin, also known as 2-acetamido-1,2,5-trideoxy-1,5-imino-D-glucitol; a gift from Dr Arnold Stütz (Institut für Organische Chemie, Technische Universität Graz, Austria), NACS (N-acetylcastanospermine, also known as 6-acetamido-6-deoxycastanospermine; Industrial Research Ltd), PUGNAc [O-(2-acetamido-2-deoxy-D-glucopyranosylidene)-amino N-phenylcarbamate] (Toronto Research Chemicals), STZ (streptozotocin) (Sigma), mannosamine (2-amino-2-deoxymannose) (Industrial Research Ltd), GlcNAc and GalNAc (Sigma). For tests with complex substrates, biantennary N-glycans were utilized as described previously , whereas H-Thr-Ala-Pro-Thr-(O-GlcNAc)-Ser-Thr-Ile-Ala-Pro-Gly-OH, corresponding to the O-GlcNAc modification site found within the primary sequence of the transcription factor CREB (cAMP-response-element-binding protein), was purchased from Invitrogen and H-Pro-Gly-Gly-Ser-Thr-Pro-Val-Ser-(O-GlcNAc)-Ser-Asn-Met-Met-Ser-Gly-OH, corresponding to a site in casein kinase II, was synthesized by Dr Nicolas Laurent (Manchester Interdisciplinary Biocentre, University of Manchester, U.K.).
Tissue-specific expression of murine hexosaminidase
For analysis of tissue-specific mRNA expression, adult wild-type mice with a mixed B6/129 background were killed by cervical dislocation, tissues (tibialis anterior, soleus, atrium, ventricle, uterus, lung, liver, kidney and brain cortex) were dissected and immediately frozen at −80 °C until further use. The provenance, maintenance and killing of mice was in accordance with the Animals (Scientific Procedures) Act 1986 as stated by U.K. law. No undue suffering of animals was caused by the experiments. RNA was extracted from tissues using TRIzol® (Invitrogen) following the manufacturer's instructions. Concentrations of RNA were measured with an UV-spectrophotometer. RNA (2 μg) was then mixed with 0.5 μg of d(T)18 and 0.5 μg of d(N)10 primers. Nuclease-free water was added to a final volume of 15 μl. The mixture was incubated at 75 °C for 5 min and subsequently cooled on ice. Then 5 μl of 5×reverse transcriptase buffer, 1.5 μl of 10 mM dNTPs, 0.5 μl of RNasin (RNase inhibitor), 2 μl of nuclease-free water and 1 μl of reverse transcriptase (M-MLV, Promega, 100 units/μl) were added. The mixture was incubated at 42 °C for 90 min. Finally, the enzyme was denatured by incubating at 75 °C for 10 min. The resulting cDNAs were normalized against the levels of GAPDH (glyceraldehyde-3-phosphate dehydrogenase) transcripts. The following primer pairs were used which cross intron/exon boundaries: 5MmHexoRT_1 (5′-ATACAGCCCGTCCGAGGTTAC-3′) and 3MmHexoRT_1 (5′-TCAGGGTGTTGGGGAAGAG-3′). PCR was performed for 40 cycles of 98 °C for 30 s, 67 °C for 20 s and 72 °C for 15 s. Furthermore, the primer pair (MouseHex/1/EcoRI and MouseHex/2/XhoI) designed to clone the full open reading frame (see above) was also employed with the various cDNAs using an annealing temperature of 56 °C and an elongation time of 80 s.
For localization studies, a vector encoding a N-terminal Myc-tag (pSG9M) was employed. Murine liver cDNA was subjected to PCR using the primers Mouse/pSG9M/1/XhoI (5′-CCGCTCGAGATGTCATCACCCACGCC-3′) and Mouse/pSG9M/2/XbaI (5′-GCTCTAGATCAGGGGTTCTGCCCTG-3′) and the resulting fragments were, after digestion, ligated into the vector; the resulting bacterial colonies were screened and plasmid DNA was prepared. Murine NIH 3T3 fibroblasts were transfected using Lipofectin®, subsequently stained with a mouse anti-Myc antibody, followed by FITC or Cy2 (carbocyanine)-labelled anti-mouse IgG and then were examined by confocal laser-scanning microscopy (Leica TCS SP2 or Zeiss LSM 510) with Ar-laser excitation at 488 nm and emission at 500–540 nm or He-Ne-laser excitation at 633 nm and emission at >650 nm using an HC Plans 10×/25 ocular and HC PL Fluotar 63×/0.30 or 63×/1.4 objective lens. Co-labelling with AlexaFluor® 633-conjugated phalloidin or DAPI (4′,6-diamidino-2-phenylindole) was also performed to detect the cytoskeleton and nucleus respectively. The cells were also examined by enzymatic assay and Western blotting with a mouse anti-Myc antibody (9E10, Sigma); in the latter case, a Myc-tagged form of Saccharomyces cerevisiae Alg1p β1,4-mannosyltransferase expressed in E. coli  was used as a positive control.
Identification and expression of novel mammalian hexosaminidase homologues
During our recent characterization of four novel β-hexosaminidases (HEX-2, HEX-3, HEX-4 and HEX-5) from the nematode C. elegans , we became aware of previous uncharacterized homologous human and murine cDNA sequences which have been annotated in genome databases with the name HEXDC. These two mammalian and four nematode sequences fall into the same subfamily, previously designated by us as ‘subfamily 1’ , of the glycohydrolase family 20 hexosaminidases. This subfamily 1 has been recently described by others, in a bioinformatic and phylogenetic study, as ‘clade B’ of the glycohydrolase family 20  and their results confirm our previous hypothesis of an evolutionary split in this group of enzymes.
Unlike the four nematode genes mentioned above, which encode proteins with predicted transmembrane domains, the two new human and murine cDNAs putatively encode proteins lacking any signal or other hydrophobic sequences and so were considered to possibly encode cytoplasmic proteins. The relevant cDNAs were isolated after RT-PCR (reverse transcription-PCR) as full-length open reading frames and introduced into E. coli expression vectors. In the case of the murine homologue, two different cDNA clones were isolated (one short form and one longer form), whereas in the case of the human one, two identical cDNAs were cloned, both of which lacked an 86 nt region present in the predicted transcript NM_173620, but which are equivalent to the newly deposited sequence with the GenBank® accession number BC018205. The short murine form and the human form, both of 486 amino acids, are encoded by twelve exons and the longer murine form by thirteen exons stretching over some 15–17 kbp of genomic sequence. Only the shorter form of the murine sequence fully corresponds to the human one; the insertion in the longer murine form, encoding an additional 73 amino acids after residue 328, displays no homology to any mammalian sequence and so is presumed to be a splicing artefact.
Both the mouse and human proteins contain the His/Asn-Xaa-Gly-Ala/Cys/Gly/Met-Asp-Glu-Ala/Ile/Leu/Val sequence typical of class 20 hexosaminidases (Figure 1); in other members of this family, the glutamate residue of this motif has been shown to be involved in the catalytic mechanism . Presumed orthologues of HEXDC sequences occur in other mammalian (horse, cow and dog, with 78–80% amino-acid identity with the murine sequence), chicken (63% identity), frog (58% identity) and fish (44% identity) genomes (results not shown). More distantly related homologues exist in bacteria, such as the StrH β-hexosaminidase from Streptococcus pneumoniae . Submission of the murine HEXDC sequence to the Phyre server  indicated that the closest relationships, to proteins with known three-dimensional structures, are to family 20 glycosidases from subfamily 2 (human lysosomal and Streptomyces plicatus hexosaminidases, Actinobacillus actinomycetemcomitans dispersin B and Serratia marcescens chitobiase; E values of 1.8e−32–1.6e−25) and more distantly to family 84 glycosidases (Bacteroides thetaiotaomicron GlcNAcase and Clostridium perfringens NagJ; E values 3e−06–9.9e−06).
The long and short murine forms, as well as the human HEXDC cDNA, were then expressed in BL21(DE3)pLysS cells and, upon induction with IPTG, hexosaminidase activity was detected in lysates of the bacterial cells (Figure 2). Initial indications, when using p-nitrophenyl substrates, were that both enzymes were relatively specific for p-nitrophenyl-β-N-acetylgalactosaminide and that His-tagged proteins of approx. 55000 Da were expressed in only the induced cells (62000 Da in the case of the murine longer form; see Figure 2), as compared to the predicted molecular masses of 54575 and 53788 Da for the murine (short) and human proteins respectively. The fact that the longer murine form is active is perhaps due to the insertion in its sequence being outside the region homologous to most other class 20 hexosaminidases of the subfamily 1.
Further characterization of murine hexosaminidase D
In order to facilitate further characterization, the enzymes were then partially purified by His tag affinity chromatography; the major portions of the activity and anti-His reactivity were in the fractions eluted with 250 mM imidazole. The identity of the purified enzymes was also verified by tryptic peptide mass fingerprinting; due to the 80% identity of the mouse short form and the human form, we performed most experiments with the murine short form, since this was more stable upon storage. Gel-filtration analysis of the purified recombinant murine short form suggested that the enzyme is predominantly present as a dimer with a native molecular mass of approx. 120000 Da (Figure 2C), whereas under denaturing conditions, SDS/PAGE and Western blotting demonstrated that a homogenous protein of approx. 55000 Da was present in fractions containing hexosaminidase activity.
Bearing in mind the hypothesis that the newly identified genes encode proteins which may correspond to so-called ‘hexosaminidase D’ activities, the affinity-purified murine enzyme was then examined considering the criteria previously used to categorize the different hexosaminidase activities detected in mammalian tissues [17–20]. The apparent relative specificity for p-nitrophenyl-β-N-acetylgalactosaminide (Figure 3A), the pH optimum of 5.5 (Figure 3B) and the relative stability to incubation at 50 °C (Figure 3C) appeared to agree well with previous data on hexosaminidase D [18,21]. The Km value for the murine enzyme was also determined (∼0.25 mM) and was in reasonable agreement to the value of 0.35 mM  also found for hexosaminidase D (Figure 3D); the temperature optimum was found to be 37 °C (Figure 3E). The pH optimum and relative temperature stability of the human and murine enzymes in E. coli lysates were similar to those of the purified murine enzyme.
The effect of various typical hexosaminidase inhibitors was also tested, specifically NACS, AdDNJ, PUGNAc, STZ, GlcNAc and GalNAc [15,22,29–34]. In the case of our novel murine hexosaminidase, only 60% inhibition with 1 mM PUGNAc and 30% with 1 mM NACS was observed when the enzyme was assayed with 2.5 mM substrate (Figure 3F). Therefore the recombinant murine hexosaminidase D shows properties which are at variance with OGA, which is inhibited by 96% by 1.25 mM PUGNAc when assayed with 2 mM p-nitrophenyl-β-N-acetylglucosaminide . It also requires far higher concentrations of PUGNAc and NACS for inhibition than Arabidopsis HEX1 and Caenorhabditis HEX-1, which are ‘typical’ (subfamily 2) class 20 hexosaminidases; these two enzymes are inhibited by 60–90% when incubated with 0.1 mM of these inhibitors under assay conditions  similar to those employed in the present study.
The relatively poor inhibition of hexosaminidase D with PUGNAc and NACS is similar to the results with the p-nitrophenyl-β-N-acetylhexosaminidase activity of four recently characterized C. elegans class 20 hexosaminidases (HEX-2, -3, -4 and -5), which are part of the same subfamily (subfamily 1) as hexosaminidase D and which also prefer p-nitrophenyl-β-GalNAc as a substrate . Considering the homology of mouse hexosaminidase D with these C. elegans enzymes displaying activity towards N-glycans, the mouse and human hexosaminidases were incubated with N-glycans carrying terminal GlcNAc or GalNAc residues; however, no digestion was observed (results not shown). Furthermore, considering the potential cytosolic localization of the enzyme, tests were also performed with two peptides modified with O-linked β-GlcNAc; the control reaction with jack bean hexosaminidase showed removal of the GlcNAc residue from the peptides, whereas no such effect occurred in the incubation with the purified murine hexosaminidase (results not shown).
Tissue-specific expression of the novel murine hexosaminidase
RT-PCR was performed using mRNA from a variety of murine tissues (various muscles, uterus, lung, liver, kidney and brain cortex), the cDNAs were normalized based on the levels of GAPDH transcript and it was found that the putative hexosaminidase D is expressed in all tissues examined, with no major differences in transcript levels (Figure 4).
Intracellular localization of the novel murine hexosaminidases
On the basis of a lack of any obvious hydrophobic domains, our hypothesis was that the murine and human forms of the putative hexosaminidase D are not, as other eukaryotic class 20 hexosaminidases, directed via the endoplasmic reticulum to the lysosome or secretory pathway, but that they are present in the nucleus or cytoplasm. Thus a plasmid encoding an N-terminally Myc-tagged form of the full-length murine hexosaminidase was engineered and transfected into murine NIH 3T3 fibroblast cells, which were then subjected to immunofluorescence and confocal microscopy. Those cells which were transfected showed that the tagged protein was present in the nucleus and the cytoplasm (Figures 5A and 5B); it is unclear whether the less elongated appearance of transfected (fluorescent) cells, as compared to the typical fibroblast morphology of the non-transfected ones, is of functional significance. Certainly, actual overexpression of the hexosaminidase was demonstrated by the appearance of a Myc-tagged protein of the appropriate molecular mass and of increased N-acetylgalactosaminidase activity in the cell lysates (Figures 5C and 5D). In an independent experiment, transfection of COS cells also showed a concentration of the Myc-tagged protein in the nucleus (Figure 5E).
A range of earlier literature suggested that, in addition to the well-known lysosomal hexosaminidases encoded by the HEXA and HEXB genes and the neutral cytosolic OGA, there may be an additional soluble hexosaminidase present in mammalian cells. In 1967, a β-N-acetylgalactosaminidase with optimal activity at pH 5.5 was found in a 100000 g supernatant of a calf brain homogenate . Later, another report on bovine brain hexosaminidases indicated the presence of four chromatographically distinguishable enzymes, hexosaminidases A, B, C and D, the latter of which was a heat-stable specific galactosaminidase ; bovine and human hexosaminidase C, on the other hand, was found as a glucosaminidase with a higher molecular mass and optimal activity in the range pH 5–7 [17,20,35] and, in retrospect, is probably identical to OGA . Finally, two rat brain neutral hexosaminidases were described which, unlike the lysosomal forms and suggestive of a lack of N-linked glycosylation, did not interact with concanavalin A: one glucosaminidase with, as determined by SDS/PAGE, a molecular mass of 130000 Da and one galactosaminidase of 55000 Da . The former apparent molecular mass also corresponds well with that of the rather heat-sensitive OGA; the galactosaminidase, on the other hand, had optimal activity at pH 6 and was relatively heat-stable.
In comparison to these results for native enzymes, the recombinant enzymes reported in the present study are soluble, are of a molecular mass of 55000 Da, are relatively stable at 50 °C, display optimal activity at pH 5.5 and prefer the galactosaminide substrate; thus it is hypothesized that these human and murine enzymes correspond to the ‘hexosaminidase D’ activities previously detected in mammalian brain extracts. Furthermore, the intracellular localization data indicate that a Myc-tagged form of the murine enzyme is localized to the nucleus and cytoplasm; interestingly, a large-scale yeast two-hybrid screen also suggests that the human enzyme has a high confidence interaction with the tubulin β4 subunit . The recombinant murine enzyme also appears to be predominantly present as a dimeric form, as is the case with the lysosomal hexosaminidases.
Thus it appears that hexosaminidase D is indeed a second nucleocytoplasmic hexosaminidase with properties other than the general intracellular location, unlike OGA which is proven to play a role in intracellular signalling; on the other hand, ‘D-type’ hexosaminidases are the only vertebrate members of a recently described new subgroup within the glycoside hydrolase family 20. Hexosaminidase D does have homologues in nematodes (C. elegans HEX-2, HEX-3, HEX-4 and HEX-5, approx. 30% identity over 440 amino acids) and in insects (Drosophila CG7985, approx. 35% identity), but the predicted proteins contain potential transmembrane regions and so, unlike hexosaminidase D, are not expected to be cytosolic proteins. No function has yet been proven for Drosophila CG7985, but all four nematode enzymes do digest selected N-glycan substrates In vitro and, as judged by N-glycan analysis of the relevant hex-2 mutant, C. elegans HEX-2 is indeed involved in N-glycan biosynthesis and so is expected to be a Golgi enzyme . Thus, whereas invertebrates possess only the family 84 OGA as a cytosolic enzyme, such as the C. elegans OGA-1 , despite having other family 20 hexosaminidases, the presence of two nucleocytoplasmic hexosaminidases appears to be confined to vertebrates. Akin to the nematode members of subfamily 1 (clade B) of family 20 and in keeping with the phylogenetic distance , the recombinant hexosaminidase D is only inhibited by relatively large inhibitor/substrate ratios when using a range of compounds, such as AdDNJ, NACS or PUGNAc, typically considered to be effective inhibitors of other family 20 hexosaminidases [29–31].
Other than O-linked GlcNAc, there are a variety of N-acetylhexosamine-containing compounds in mammalian cells, including mucin-type O-glycans (α-linked GalNAc linked to Ser/Thr residues), various glycolipids (such as the β-GalNAc-containing ganglioside GM2, whose catabolism is blocked in Tay–Sachs and Sandhoff syndromes), N-glycans (containing β-linked GlcNAc and, occasionally, GalNAc) and glycosaminoglycans (with both α- and β-linked hexosamine-containing repeating units); these, although, are all products of the secretory pathway. In the case of N-glycans, some cytosolic exoglycosidase-mediated degradation does occur, for instance via the action of the Man2c1 α-mannosidase on oligomannosidic glycans derived from misfolded proteins . It is also noteworthy that mammalian Neu2 sialidases display a similar localization and pH optimum to hexosaminidase D ; however, unlike hexosaminidase D, Neu2 can cleave sialic acid from N-glycans [40,41] as well as from glycolipids .
Although, as mentioned above, hexosaminidase D may interact with β-tubulin, a protein shown to carry O-GlcNAc residues , we detected no activity towards O-GlcNAc-modified peptides. Thus it appears that hexosaminidase D may not constitute part of another route for control of the balance between O-GlcNAc and phosphorylation of vertebrate cytosolic and nuclear proteins or it may require another co-factor for such an activity or display a unique substrate specificity. On the other hand, its cytoplasmic localization would argue against a role in the metabolism of N-, O- or lipid-linked oligosaccharides originating from the secretory pathway, although non-classical secretion of this enzyme cannot be ruled out; therefore the functional and biological significance of this enzyme remains to be resolved.
This work was supported by the Austrian Fonds zur Förderung der wissenschaftlichen Forschung [grant numbers P15475, P18447 (to I.B.H.W.)].
We wish to thank Andreas Rupp, project student in our laboratory, for performing Western blotting, Dr Boris Ferko (Universität für Bodenkultur Wien, Vienna, Austria) for the sample of mouse liver, as well as Dr Elisabeth Ehler (King's College London, London, U.K.) for facilitating the work of T. I. on this project, Dr Johannes Grillari (Universität für Bodenkultur Wien, Vienna, Austria) for the pSG9M vector and helpful discussions, Dr Arnold Stütz and Dr Nicolas Laurent for the gifts of AdDNJ and a chemically synthesized peptide respectively, and Dr Katharina Paschinger for reading the manuscript.
Abbreviations: AdDNJ, 2-acetamido-1,2-dideoxynojirimycin; GalNAc, N-acetylgalactosamine; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GlcNAc, N-acetylglucosamine; IPTG, isopropyl β-D-thiogalactoside; NACS, N-acetylcastanospermine; OGA, O-GlcNAcase; PUGNAc, O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino N-phenylcarbamate; RT-PCR, reverse transcription-PCR; STZ, streptozotocin
- © The Authors Journal compilation © 2009 Biochemical Society